In addition, IFX treatment by AC-IFX-L and EAC-IFX-L-based nanocomposites not only showed a significant anti-inflammatory effect, but also remarkably decreased TNF-α level in a DSS-induced mouse colitis model. The gene discussed is TNF; the disease is colitis.